… Bivalent and quadrivalent human papillomavirus (HPV) vaccines are available that are
highly efficacious against persistent vaccine-type HPV infections and associated intraepithelial …

… This review discusses the future directions of therapeutic HPV vaccine approaches for the
… of HPV vaccine clinical trials. Table 3 lists the various therapeutic HPV vaccine clinical trials. …

… of clinical trial results for the two licensed prophylactic human papillomavirus (HPV) vaccines,
… It emphasizes the end of study analyses of the pivotal phase III trials in young women that …

… Human papillomavirus and lower … clinical trials to confirm that the vaccine can prevent
HPV-associated disease, and the expansion of the number of HPV types included in the vaccine to …

… of therapeutic HPV vaccines through clinical trials may … clinical trials for therapeutic HPV
vaccines. The ultimate goal for therapeutic HPV vaccine is the progression through clinical trials …

… The high efficacy found in prelicensure clinical trials has been confirmed by dramatic impact
and effectiveness observed in national immunization programs over the past decade [2]. …

… We acknowledge that female participants from the ITT population from previous HPV
vaccine clinical trials evaluation are likely to be slightly older (18–26 years old) than the full age …

… vaccine trial to prevent “Human Papillomavirus, a sexually transmitted disease.” It was explained
that this trial … At various visits they would receive shots, pelvic exams, have blood drawn, …

… This review discusses the current status of HPVs vaccines on the global market, clinical
trials… The phase I clinical trial of the qHPV vaccine was designed to investigate the dose …

… In addition, pan-gender vaccination and current clinical trials are also discussed. Currently,
… effects following the introduction of human papillomavirus vaccination programmes: Updated …